Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00969449 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan
A Phase 1 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT00969449: Completed Phase 1 study, sponsored by Bayer.
NCT00969449 is a Phase 1 study that has completed, run by Bayer. The registered enrollment target is 28 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00969449, a Phase 1 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
To compare the pharmacokinetic profile of the proposed extended- release tablet of naproxen sodium 660 mg relative to two tablets of Naprelan 500 mg following single dose administration for 36 hours under fasted conditions
Interventions
- DRUG Naproxen Sodium, (BAY H6689)
- DRUG Naprelan, (BAY H6689)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
What the finished NCT00969449 record still lists
NCT00969449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 2 interventions - of which Naproxen Sodium, (BAY H6689) is the first listed.
NCT00969449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00969449 about?
NCT00969449 is a clinical study titled "Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan". To compare the pharmacokinetic profile of the proposed extended- release tablet of naproxen sodium 660 mg relative to two tablets of Naprelan 500 mg following single dose administration for 36 hours under fasted conditions
What is the current status of trial NCT00969449?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2009-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00969449?
The interventions under investigation include: Naproxen Sodium, (BAY H6689) (DRUG), Naprelan, (BAY H6689) (DRUG).
Who is sponsoring clinical trial NCT00969449?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00969449's enrollment target sits among peer trials
28 1447th of 2000 higher than 538 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia